Browse Studies — Arctuva

Phase 2

A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency

This phase II trial tests how well immunotherapy (toripalimab) works for reducing the risk of cancer recurrence after surgery in patients with mismatch repair …

Localized Colon CarcinomaStage IIB Colon Cancer AJCC v8Stage IIC Colon Cancer AJCC v8+1 more

Estimated

~$10 – $6,250

Emory UniversityNCT07140679

Observational

Evaluation of Provider vs. Patient Mediated Cascade Genetic Testing of First-Degree Relatives of Patients With Newly Diagnosed Colorectal Cancer

This clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relative…

Colon AdenocarcinomaColorectal AdenocarcinomaRectal Adenocarcinoma+12 more

Estimated

~$10 – $6,250

Alliance for Clinical Trials in OncologyNCT07143487

Observational

Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers: Human-Centered Study

This clinical trial develops and tests a mobile health (mHealth) intervention to improve adherence to lifestyle recommendations in colorectal cancer (CRC) surv…

Stage I Colon Cancer AJCC v8Stage I Rectal Cancer AJCC v8Stage II Colon Cancer AJCC v8+3 more

Estimated

~$10 – $6,250

Ohio State University Comprehensive Cancer CenterNCT06746012

Phase 2

A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer

This phase II trial studies how well giving zanidatamab before surgery (neoadjuvant) works in treating patients with colon and rectal cancer that is human epid…

Colon CarcinomaColorectal CarcinomaRectal Carcinoma+9 more

Estimated

~$10 – $6,250

Emory UniversityNCT07405476